Bradykinesia in Alzheimer's disease and its neurophysiological substrates.


Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
04 2020
Historique:
received: 01 11 2019
revised: 11 12 2019
accepted: 29 12 2019
pubmed: 18 2 2020
medline: 19 12 2020
entrez: 18 2 2020
Statut: ppublish

Résumé

Alzheimer's disease is primarily characterized by cognitive decline; recent studies, however, emphasize the occurrence of motor impairment in this condition. Here, we investigate whether motor impairment, objectively evaluated with kinematic techniques, correlates with neurophysiological measures of the primary motor cortex in Alzheimer's disease. Twenty patients and 20 healthy subjects were enrolled. Repetitive finger tapping was assessed by means of a motion analysis system. Primary motor cortex excitability was assessed by recording the input/output curve of the motor-evoked potentials and using a conditioning-test paradigm for the assessment of short-interval intracortical inhibition and short-latency afferent inhibition. Plasticity-like mechanisms were indexed according to changes in motor-evoked potential amplitude induced by the intermittent theta-burst stimulation. Patients displayed slowness and altered rhythm during finger tapping. Movement slowness correlated with reduced short-latency afferent inhibition in patients, thus suggesting that degeneration of the cholinergic system may also be involved in motor impairment in Alzheimer's disease. Moreover, altered movement rhythm in patients correlated with worse scores in the Frontal Assessment Battery. This study provides new information on the pathophysiology of altered voluntary movements in Alzheimer's disease. The study results suggest that a cortical cholinergic deficit may underlie movement slowness in Alzheimer's disease.

Identifiants

pubmed: 32066104
pii: S1388-2457(20)30027-4
doi: 10.1016/j.clinph.2019.12.413
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

850-858

Informations de copyright

Copyright © 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Matteo Bologna (M)

Department of Human Neurosciences, Sapienza University of Rome, Italy; IRCCS Neuromed, Pozzilli (IS), Italy.

Andrea Guerra (A)

IRCCS Neuromed, Pozzilli (IS), Italy.

Donato Colella (D)

Department of Human Neurosciences, Sapienza University of Rome, Italy.

Ettore Cioffi (E)

Department of Human Neurosciences, Sapienza University of Rome, Italy.

Giulia Paparella (G)

IRCCS Neuromed, Pozzilli (IS), Italy.

Antonella Di Vita (A)

Department of Human Neurosciences, Sapienza University of Rome, Italy.

Fabrizia D'Antonio (F)

Department of Human Neurosciences, Sapienza University of Rome, Italy.

Alessandro Trebbastoni (A)

Department of Human Neurosciences, Sapienza University of Rome, Italy.

Alfredo Berardelli (A)

Department of Human Neurosciences, Sapienza University of Rome, Italy; IRCCS Neuromed, Pozzilli (IS), Italy. Electronic address: alfredo.berardelli@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH